Skip to main content
Equibles

RA CAPITAL MANAGEMENT, L.P.

Position in PEPG — PepGen Inc.

CIK 1346824 BOSTON, MA
Back to PEPG Full portfolio

Position in PEPG

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$36,116,181
+$601,937 QoQ
Shares Held
20,064,545
0.0% QoQ
Ownership
29.0%
of shares outstanding
% of Portfolio
0.32%
of 13F equity value
Holder Rank
#1
of 72 holders
Holding Since
Jun 2022
17 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PEPG Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

RA CAPITAL MANAGEMENT, L.P. holds $11,082,969,028 across 75 Biotechnology names. PEPG ranks #46 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ASND
Ascendis Pharma A/S
 10,281,496 $2,742,280,613
2 PBLS
Parabilis Medicines, Inc.
 28,933,371 $791,906,364
3 RYTM
Rhythm Pharmaceuticals, Inc.
 6,666,837 $740,218,912
4 PCVX
Vaxcyte, Inc.
 11,474,599 $667,018,439
5 SION
Sionna Therapeutics, Inc.
 9,905,045 $435,722,929
6 TYRA
Tyra Biosciences, Inc.
 12,198,625 $389,624,082
7 EWTX
Edgewise Therapeutics, Inc.
 8,392,730 $340,996,619
8 NAMS
NewAmsterdam Pharma Co N.V.
 9,883,524 $330,779,298

All Filings in PEPG

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $36,116,181 20,064,545
2026-03-31 $35,514,244 20,064,545
2025-12-31 $130,620,187 20,064,545
2025-09-30 $92,698,197 20,064,545
2025-06-30 $11,865,394 10,689,545
2025-03-31 $15,018,810 10,689,545
2024-12-31 $40,513,375 10,689,545
2024-09-30 $91,395,609 10,689,545
2024-06-30 $170,605,138 10,689,545
2024-03-31 $157,136,311 10,689,545
2023-12-31 $55,297,273 8,131,952
2023-09-30 $41,310,316 8,131,952
2023-06-30 $72,699,650 8,131,952
2023-03-31 $99,453,772 8,131,952
2022-12-31 $108,724,198 8,131,952
2022-09-30 $73,838,124 8,131,952
2022-06-30 $80,750,283 8,131,952